alexa New Theory And Efficacy Of CXL
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

10th International conference on Ophthalmology and Optometry
August 10-11, 2017 Beijing, China

Jui-Teng Lin
New Vision Inc., Taiwan
ScientificTracks Abstracts: J Clin Exp Ophthalmol
DOI: 10.4172/2155-9570-C1-063
Abstract
We will present a new analytic Z* formula for corneal cross linking (CXL). CXL safety the criteria for the validity of Bunsen- Roscoe law (BRL) for accelerated CXL and its comparison to the new nonlinear law will be discussed. New formulas for CXL efficacy for both type-I and type-II will be presented. The minimum corneal thickness given by a Z*-formula, Z*=(1/A’) ln(E*/Ed), where a steady state effective absorption constant given by A’=2.3[mε2G(z)C0+Q], where Ed is the endothelial cell’s cytotoxic damage energy threshold (Ed). CXL efficacy (for type-I) is given by Ceff=1-exp(-S) with S being the rate function. The Bunsen-Roscoe law (BRL) is based on the Beer-Lambert law for UV light intensity without RF depletion, such that S=akE, which is a linear function of the dose E=(tI). In comparison, using a time-dependent generalized Beer-Lambert law, we obtain S=√(4kCo/aIo) exp(A'z) [1-exp(-0.5aE] which is a nonlinear function of E and has a steady-state proportional to √(Co/aIo) exp(A'z). Our nonlinear law predicts that high UV intensity requires longer exposure time than what is calculated based on BRL. In addition, for the same dose, higher intensity depletes the RF faster and reaches a lower steady-state efficacy than that of lower intensity, consistent with the recent clinical data. The CXL efficacy (for type-II) is given by Ceff=1-exp(-S) with S is the time integral of the singlet oxygen concentration, given by S(z,t)=(k7/k4)b1 V(z,t)[1-b2 V(z,t)] , where V(z,t)=ln (1+Bt), with B=apqI(z)X0., where X0 is the initial oxygen concentration, p and q are the type-I and type-II quantum yield, respectively. The S formula provides the role of oxygen in type-II efficacy.
Biography

Jui-Teng Lin has completed his PhD in Physics from the University of Rochester in USA. He is currently the Chairman and CEO of New Vision Inc., and Visiting Professor at HE Medical University in China. He has served as a Visiting Professor at National Chao Tung University and was the Associate Professor at the University of Central Florida. He holds over 45 patents and is the Inventor of flying spot LASIK procedure. He has published over 55 book chapters and over 150 peer review journal papers including 75 SCI-impacted papers.

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords